Net Profit Margin ratio Analysis of Acasti Pharma Inc - Deep Dive
Latest FY NPM
Period Ending - Mar-23
Poor NPM
0
Period Ending - Mar-22
Very Poor NPM
-75530.77
Growth
0 %
Trailing Twelve Months NPM
Period Ending - Mar-23
Excellent NPM
123465
Most recent Quarter NPM
Period Ending - Dec-23
Poor NPM
0
NPM Analysis of Acasti Pharma Inc
NPM Ratio of Acasti Pharma Inc with value of 123465 indicates that a company is able to control its costs effectively and offer goods or services at a much higher price than its costs in trailing twelve months. |
NPM Ratio of ACST has grown by 0 % Compared to previous Financial Year. |
NPM Ratio with value of 0 was highest in Year Mar-23 in last Five Years. |
NPM Ratio with value of -75530.77 was lowest in Year Mar-22 in last Five Years. |
Latest NPM Ratio with value of 0 is Greater than Average NPM of -18012.58 in last five years. |
Other NPM Related Info of ACST that may interest you.
Acasti Pharma Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
ACST | 2.69 | 2.7599 | 2.53 % | Biotechnology |
Defination of Net Profit Margin
Net Margin is the company's Net Profit divided by the Total Revenue. This profitability metric indicates how much a net profit is generated for each rupee of revenue earned. In simple terms, it tells how much the company is generating profit for each rupee of revenue earned in percentage. It measures the company's profitability and management's capability to manage its expenses to generate profit. more ..NPM Related Ratios
ReturnOnEquity | EBITDAMargin |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical Net Profit Margin of Acasti Pharma Inc
Period | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
---|---|---|---|---|---|---|---|
NPM | 0 | -75530.77 | -14532.14 | 0 | 0 | 0 | 0 |
Change | 0 % | -419.75 % | 0 % |
FY Chart of Net Profit Margin of Acasti Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)